Dec
9
7:00 am07:00

New Insights on Elective Single Embryo Transfer from Nationwide IVF Patient Survey to be presented at the American Society for Reproductive Medicine

Progyny, the leading company dedicated to helping ensure patients control their fertility journey and achieve the best possible outcomes, announced today new insights on factors associated with increased likelihood of acceptance of elective single embryo transfer (eSET) for patients undergoing IVF from a nationwide IVF patient survey will be presented at the American Society for Reproductive Medicine (ASRM) in Baltimore, MD.

Click here to view.

Dec
9
7:00 am07:00

Progyny Presents Abstract on Increasing Access to Fertility Care at Annual Fertility Conference

Progyny, a leading digital healthcare company, today announced Karin Ajmani, president of healthcare services at Progyny, will present the abstract titled, “Employer Engagement and Education Increases Access to Care and eSET Utilization,” at the American Society for Reproductive (ASRM) Medicine 2016 Scientific Congress in Salt Lake City.

Click here to view.

Dec
9
7:00 am07:00

Progyny Adds Depth to Executive Team

Karin Ajmani and Brian Dow join Progyny, Inc. to drive financial growth post-merger for Auxogyn and FertilityAuthority. Progyny, the first company to provide fertility patients with easy accessibility to high quality doctors, price transparency, financing and extraordinary clinical solutions, is proud to announce the addition of Karin Ajmani as President of Healthcare Services, and Brian Dow as Chief Financial Officer. Both Ms. Ajmani and Mr. Dow will play key roles in building and supporting Progyny’s expansion of services in the reproductive health space.

Click here to view.

Dec
9
7:00 am07:00

Progyny Announces Scientific Sessions on the Eeva Test at the Annual Meeting of the American Society for Reproductive Medicine

Progyny, the leading company dedicated to helping ensure patients control their fertility journey and achieve the best possible outcomes, announced today that new clinical research data associated with use of its Eeva™ Test will be highlighted this week during scientific sessions at the American Society for Reproductive Medicine (ASRM) in Baltimore, MD.

Click here to view.

Dec
9
7:00 am07:00

New Insights on Elective Single Embryo Transfer from Nationwide IVF Patient Survey to be presented at the American Society for Reproductive Medicine

Progyny, the leading company dedicated to helping ensure patients control their fertility journey and achieve the best possible outcomes, announced today new insights on factors associated with increased likelihood of acceptance of elective single embryo transfer (eSET) for patients undergoing IVF from a nationwide IVF patient survey will be presented at the American Society for Reproductive Medicine (ASRM) in Baltimore, MD.

Click here to view.

Dec
9
7:00 am07:00

Announcing Progyny: Combining Best-in-Class Clinical Solutions with Consumer Expertise

Progyny Raises New Round to Fund Clinical Solutions that Improve Patient Outcomes. Progyny, Inc., the new combined entity of Auxogyn, Inc. and Fertility Authority, LLC, announced that it has secured additional capital from investors including Kleiner Perkins Caufield & Byers (KPCB), TPG Biotech, SR One and Merck Serono Ventures.

Click here to view.

Dec
9
6:30 am06:30

Progyny Adds Depth to Executive Team

Karin Ajmani and Brian Dow join Progyny, Inc. to drive financial growth post-merger for Auxogyn and FertilityAuthority. Progyny, the first company to provide fertility patients with easy accessibility to high quality doctors, price transparency, financing and extraordinary clinical solutions, is proud to announce the addition of Karin Ajmani as President of Healthcare Services, and Brian Dow as Chief Financial Officer. Both Ms. Ajmani and Mr. Dow will play key roles in building and supporting Progyny’s expansion of services in the reproductive health space

Click here to view.

Dec
9
6:30 am06:30

Auxogyn and Fertility Authority to Merge

Aligning Science, Technology, Clinics, and Patients for the Best Fertility Outcome. Auxogyn, Inc. and Fertility Authority, LLC today announced the merger of the two companies. The combined company will be the first to provide fertility patients with easy accessibility to high quality doctors, price transparency and financing, extraordinary clinical expertise, and proprietary clinical solutions under one roof.

Click here to view.